IpiNovyx Bio Revenue and Competitors
Estimated Revenue & Valuation
- IpiNovyx Bio's estimated annual revenue is currently $5.2M per year.
- IpiNovyx Bio's estimated revenue per employee is $77,500
- IpiNovyx Bio's total funding is $10M.
Employee Data
- IpiNovyx Bio has 67 Employees.
- IpiNovyx Bio grew their employee count by 0% last year.
IpiNovyx Bio's People
Name | Title | Email/Phone |
---|
IpiNovyx Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is IpiNovyx Bio?
IpiNovyx Bio is developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders. Once validated in the clinic, this groundbreaking technology will open the door to a whole new way to treat multiple autoimmune and complex inflammatory diseases, allowing patients to enjoy a healthier tomorrow.
keywords:N/A$10M
Total Funding
67
Number of Employees
$5.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.4M | 69 | 0% | N/A |
#2 | $30.4M | 94 | -5% | N/A |
#3 | $41.8M | 211 | 10% | N/A |